AstraZeneca (AZN) Stock Target Raised as Goldman Sachs Sees $3.7 Billion Drug Potential

27 9 月, 2025

One Min Read

7 Views

原文: https://finance.yahoo.com/news/astrazeneca-azn-stock-target-raised-045912048.html

Last Update: 27 9 月, 2025

Written By

Other Articles

Previous

Biogen (BIIB) Expands Neurology Pipeline With Alcyone Buyout, Stock Seen Undervalued

Next

Piper Sandler Reaffirms Jazz Pharmaceuticals (JAZZ) Price Target Ahead of Trial Data

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept